(Q26822549)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Lars Boeckmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Michael R Schön

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Kai-Martin Thoms

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Steffen Schubert

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Annika Schäfer

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Steffen Emmert

7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

1 reference

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

published in

Experimental Dermatology

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

21

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

2-6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

Genome maintenance mechanisms for preventing cancer

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Mechanisms of mutation formation with long-wave ultraviolet light (UVA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Quality control by DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Syndromes with genetic instability: model diseases for (skin) cancerogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Organ transplantation and skin cancer: basic problems and new perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Skin cancers after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Skin cancer in organ transplant recipients--where do we stand today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Molecular concepts of virus infections causing skin cancer in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Nucleotide excision repair and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

DNA repair and aging in basal cell carcinoma: a molecular epidemiology study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Lessons learned from DNA repair defective syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

A population-based study of skin cancer incidence and prevalence in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Influence of immunosuppression on the prevalence of cancer after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Immunosuppressants and skin cancer in transplant patients: focus on rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Branches on the alpha-C atom of cyclosporin A residue 3 result in direct calcineurin inhibition and rapid cyclophilin 18 binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

The immunosuppressive drugs cyclosporin A and tacrolimus inhibit membrane depolarization-induced CREB transcriptional activity at the coactivator level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Distinct inhibitory effects of tacrolimus and cyclosporin a on calcineurin phosphatase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Cyclosporin-A suppresses p53-dependent repair DNA synthesis and apoptosis following ultraviolet-B irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

DNA repair in mononuclear cells: role of serine/threonine phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

p53-dependent apoptosis in melanoma cells after treatment with camptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

p53 modulation of TFIIH-associated nucleotide excision repair activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Azathioprine and UVA light generate mutagenic oxidative DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Novel DNA lesions generated by the interaction between therapeutic thiopurines and UVA light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Reactive oxygen species generated by thiopurine/UVA cause irreparable transcription-blocking DNA lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Immune effector cells produce lethal DNA damage in cells treated with a thiopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Expression of DNA mismatch repair proteins and MSH2 polymorphisms in nonmelanoma skin cancers of organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

mTOR inhibitors: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

The TOR pathway: a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Activation of p70 ribosomal protein S6 kinase is an essential step in the DNA damage-dependent signaling pathway responsible for the ultraviolet B-mediated increase in interstitial collagenase (MMP-1) and stromelysin-1 (MMP-3) protein levels in huma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Rapamycin inhibits yeast nucleotide excision repair independently of tor kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

The mTOR inhibitor rapamycin suppresses DNA double-strand break repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Checkpoint kinase ATR promotes nucleotide excision repair of UV-induced DNA damage via physical interaction with xeroderma pigmentosum group A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Phosphorylation of XPB helicase regulates TFIIH nucleotide excision repair activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

PP2A regulates ionizing radiation-induced apoptosis through Ser46 phosphorylation of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Transcription factors of the NFAT family: regulation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

The CBP co-activator stimulates E2F1/DP1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

Xenotransplantation and Its Implications: Background Information for the Press

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

The effect of donor age on the processing of UV-damaged DNA by cultured human cells: reduced DNA repair capacity and increased DNA mutability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

7 January 2021

Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

7 January 2021

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

7 January 2021

Cyclosporin A inhibits Ca2+-mediated upregulation of the DNA repair enzyme DNA polymerase beta in human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

7 January 2021

Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

7 January 2021

Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

7 January 2021

Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01413.X

7 January 2021

10.1111/J.1600-0625.2011.01413.X

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

4677015

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22151386%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

4677015

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

4677015